Sign in
  • Pharmacology 2025Become a member today
  • My BPS
AboutCOVID-19Careers in pharmacologyNewsEventsEducation & engagementPartner with UsPublishingMembership & awardsMy BPS & resources

Who we are

  • Fellows
  • Honorary Fellows
  • Council
  • Committee Chairs - Vice Presidents

What we do

  • Aims & objectives
  • Strategic Plan 2022-2024
  • Annual review & accounts

Policy positions and statements

  • Consultation responses
  • Open consultations
  • Policy statements

About pharmacology

  • Explore pharmacology
  • What is clinical pharmacology
  • History of pharmacology
  • Lives remembered

Our campaigns

  • Personalised Prescribing
  • Focus on Pharmacology
  • Early Career Pharmacologists
  • Equity, diversity & inclusion (EDI) in pharmacology
  • Clinical Pharmacology Skills Alliance (CPSA)
  • Films on pharmacology

Donations

Our response and support

How you can help

Resources and trusted information

Society news and updates

COVID-19 safety at our events

Junior School (ages 7-11)

Senior school (ages 11-16)

Students (ages 16+)

Undergraduate

Postgraduate and early career

Clinical Pharmacology: for medical students

Beyond Medical School

School teacher or careers advisor

Pharmacology Educator

Where can pharmacology take me?

  • Case Studies

Finding Funding

Jobs & opportunities

  • Latest jobs
  • Internships & placements
  • Work with us
  • Volunteer with us

Latest News

Blog

Events calendar

Propose an event

Sponsor our meetings & events

Abstracts guidance & advice

Bursaries

Code of conduct for meetings and events

COVID-19 safety at our events

List an event

About BPS education

Teaching pharmacology

Society training opportunities

Engagement

Ambassadors Scheme

Educational Resources

Clinical pharmacology

Prescribing and patient safety

Animal research

Why partner with the British Pharmacological Society?

Our reach

Partnership case studies

Our principles for working with commercial third-party partners

Get in touch

Blog

  • Blog
  • Author Guidelines

Pharmacology Matters

  • About
  • Pitching your content to the BPS
  • Guide for creating BPS Content
  • Archive

British Journal of Pharmacology

British Journal of Clinical Pharmacology

Pharmacology Research & Perspectives

Guide to PHARMACOLOGY

Become a peer reviewer

Society membership

Prizes, awards and grants

  • Awards Terms & Conditions

Bursaries

  • Care Support Bursary
  • BPS Travel Bursary
  • Non-BPS Meetings Bursary

My BPS

Get involved

Documents and forms

  • Home
  • Publishing

Antinuclear antibodies in patients on acebutolol.

Article date: May 1980

By: RJ Booth, JY Bullock, JD Wilson, in Volume 9, Issue 5, pages 515-517

DOI: 10.1111/j.1365-2125.1980.tb05848.x

View this article

  • Full article (html)
  • Enhanced article (html)
  • PDF
  • References

Share this page

Previous

Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.

Next

Some further evidence for partial agonist activity of labetalol.

Publishing

  • Blog
  • Pharmacology Matters
  • British Journal of Pharmacology
  • British Journal of Clinical Pharmacology
  • Pharmacology Research & Perspectives
  • Guide to PHARMACOLOGY
  • Become a peer reviewer

Contact us

About this website

Become a member

BPS Assessment Ltd


BPS on LinkedIn BPS on Bluesky BPS on Facebook BPS on Instagram BPS on Reddit BPS on ThreadsBPS on YouTube

British Pharmacological Society is a registered UK charity - Charity No. 1030623. It is also a company limited by guarantee registered in England and Wales - Company Number 2877400.
Its registered office is The Schild Plot, 16 Angel Gate, City Road, London, EC1V 2PT, United Kingdom

© 2025 British Pharmacological Society. All rights reserved.